Show simple item record

dc.contributor.authorStaffurth, J
dc.contributor.authorHaviland, J
dc.contributor.authorWilkins, A
dc.contributor.authorSyndikus, I
dc.contributor.authorKhoo, V
dc.contributor.authorBloomfield, D
dc.contributor.authorParker, C
dc.contributor.authorLogue, John P
dc.contributor.authorScrase, C
dc.contributor.authorBirtle, A
dc.contributor.authorMalik, Z
dc.contributor.authorPanades, M
dc.contributor.authorEswar, C
dc.contributor.authorGraham, J
dc.contributor.authorRussell, M
dc.contributor.authorKirkbride, P
dc.contributor.authorO'Sullivan J
dc.contributor.authorCruickshank, C
dc.contributor.authorDearnaley, D
dc.contributor.authorHall, E
dc.date.accessioned2018-12-10T11:48:57Z
dc.date.available2018-12-10T11:48:57Z
dc.date.issued2018en
dc.identifier.citationStaffurth J, Haviland J, Wilkins A, Syndikus I, Khoo V, Bloomfield D, et al. Impact of prostate cancer hypofractionation on patient reported outcomes: baseline to 5 years change in the CHHIP Trial. Int J Radiat Oncol Biol Phys. 2018;102(3):S1-2.en
dc.identifier.urihttp://hdl.handle.net/10541/621424
dc.language.isoenen
dc.titleImpact of prostate cancer hypofractionation on patient reported outcomes: baseline to 5 years change in the CHHIP Trial.en
dc.typeMeetings and Proceedingsen
dc.contributor.departmentVelindre Cancer Centre, Cardiff, United Kingdom,en
dc.identifier.journalInternational Journal of Radiation Oncology Biology Physicsen


This item appears in the following Collection(s)

Show simple item record